Summit X, LLC
- SEC CIK
- 0001697729
- Latest filing
- Nov 13, 2025
SER holding history
Serina Therapeutics, Inc. in every 13F filed by Summit X, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
SER overviewAll 13F holders of SERFull Q3 2025 holdings
- Shares (Q1 2024)
- 0
- Sold out in Q1 2024
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 12
- Since Q1 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q1 2024 | 0 | $0 | 0.0% | −643−100.0% | Sold outConverted for a 1-for-35 split | Holders |
| Q4 2023 | 22,500 | $8.66K | <0.1% | −14,500−39.2% | Reduced | Holders |
| Q3 2023 | 37,000 | $25.2K | <0.1% | +12,000+48.0% | Added | Holders |
| Q2 2023 | 25,000 | $22.3K | <0.1% | −7,500−23.1% | Reduced | Holders |
| Q1 2023 | 32,500 | $21.5K | <0.1% | −500−1.5% | Reduced | Holders |
| Q4 2022 | 33,000 | $19.0K | <0.1% | +500+1.5% | Added | Holders |
| Q3 2022 | 32,500 | $18.0K | <0.1% | −500−1.5% | Reduced | Holders |
| Q2 2022 | 33,000 | $19.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2022 | 33,000 | $28.0K | <0.1% | +7,500+29.4% | Added | Holders |
| Q4 2021 | 25,500 | $28.0K | <0.1% | +5,000+24.4% | Added | Holders |
| Q3 2021 | 20,500 | $19.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2021 | 20,500 | $32.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2021 | 20,500 | $33.0K | <0.1% | – | – | Holders |
Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.